Page last updated: 2024-08-16

phenylpropanolamine and Bladder, Overactive

phenylpropanolamine has been researched along with Bladder, Overactive in 197 studies

Research

Studies (197)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's105 (53.30)29.6817
2010's91 (46.19)24.3611
2020's1 (0.51)2.80

Authors

AuthorsStudies
Deo, A; Dhamala, JN; Pradhan, T; Yadav, SK1
Wein, AJ1
Kasyan, GR; Kupriyanov, YA; Pushkar, DY1
Devlin, N; Hakimi, Z; Herdman, M; Hoyle, C; Nazir, J; Odeyemi, IA; Pavesi, M1
Angulo, JC; Blauwet, MB; Cambronero, J; Dorrepaal, C; Herschorn, S; Khullar, V; Martin, NE; Nitti, VW; Siddiqui, E; van Kerrebroeck, P1
Mauseth, SA; Skurtveit, S; Spigset, O1
De Nunzio, C; Tubaro, A1
Creanga, D; Ginsberg, D; Kelleher, C; Martire, DL; Schneider, T; Swift, S; Van Kerrebroeck, P1
Abrams, P; Hart, WM; Munro, V; Nazir, J; Retsa, P1
Barkin, J; Chughtai, B; Elterman, DS; Kaplan, SA1
Li, Y; Liu, X; Shi, Y; Sui, C; Sun, F; Wu, Y; Zhou, Y1
Abrams, P; Andersson, KE; Chapple, CR; Deacon, S; Kuwayama, T; Masuda, T; Radziszewski, P; Small, M1
Kishi, M; Ogata, T; Shibata, C; Sugiyama, M; Takahashi, O; Tateno, F; Tsuyusaki, Y; Uchiyama, T; Yamamoto, T; Yamanishi, T; Yano, M1
de Groat, WC; Matsuta, Y; Roppolo, JR; Schwen, Z; Shen, B; Tai, C; Wang, J1
Lin, KL; Liu, CM; Long, CY; Shen, CJ; Wang, CL; Wu, CH1
Jiang, YH; Kuo, HC; Liu, HT1
Akino, H; Fujiuchi, Y; Fuse, H; Kitagawa, Y; Miyazawa, K; Namiki, M; Suzuki, K; Yokoyama, O1
Arumi, D; Lizarraga, I; Miranda, P; Rejas, J; Sánchez-Ballester, F1
Aguado-Jodar, A; Ibáñez-Nolla, J; Kvasz, M; Navarro-Artieda, R; Rejas, J; Ruiz-Torrejón, A; Sicras-Mainar, A1
He, JY; Shi, GW; Wang, YY; Zhang, YB1
Gotoh, M; Homma, Y; Igawa, Y; Ikeda, Y; Kakizaki, H; Marui, E; Nishizawa, O; Ohkawa, S; Seki, N; Takeda, M; Yamaguchi, O; Yokoyama, O; Yoshida, M1
Angulo, JC; Kvasz, M; Linden, K; Rejas, J; Snedecor, SJ; Valpas, A1
Herschorn, S; Kaplan, SA; Ntanios, F; Sun, F1
Costello, AJ; Cummings, SR; Jacobs, BP; Lipset, CH; Orri, M1
Dai, W; Fu, L; Li, Y; Liu, W; Liu, X; Sun, F; Teng, L; Wu, Y; Zhao, J1
Kosilov, KV; Kosilova, LV; Krasnykh, MA; Loparev, SA1
Blauwet, MB; Chapple, CR; Huang, M; Kaplan, SA; Khullar, V; Mitcheson, D; Siddiqui, E1
Bu, SY; Cao, CX; Duan, X; Peng, CD; Wang, KJ; Wu, T1
Chen, J; Guo, C; Liao, X; Tang, H; Wang, Y; Yu, T1
Athanasopoulos, A; Gibson, W; Goldman, H; Madersbacher, H; Newman, D; Spinks, J; Wagg, A; Wyndaele, JJ1
Brunocilla, E; Carini, M; De Nunzio, C; Gacci, M; Gravas, S; Novara, G; Oelke, M; Salvi, M; Schiavina, R; Sebastianelli, A; Serni, S; Tubaro, A1
Li, J; Li, P; Liu, B; Wang, Y; Wu, Y1
Eftekhar, T; Ghajarzadeh, M; Miri, E; Naeimi, M; Nikfallah, A; Teimoory, N1
Aballéa, S; Garnham, A; Hakimi, Z; Maman, K; Nazir, J; Odeyemi, IA; Thokagevistk, K; Toumi, M1
Ariogul, S; Cankurtaran, E; Cankurtaran, M; Ergen, A; Esin, E; Halil, M; Kuyumcu, ME; Ozcan, M; Ulger, Z; Yavuz, BB; Yeşil, Y1
Azimi Nekoo, E; Ghanbari, Z; Haghollahi, F; Hashemi, S; Jafarabadi, M; Nemati, M1
Chiang, CH; Chin, Hy; Lin, KC; Wang, CJ2
Bavendam, T; Carlsson, M; Chancellor, M; Guan, Z; Kaplan, SA; Roehrborn, CG1
Bolodeoku, J; Khullar, V; Mundy, A; Odeyemi, I; Speakman, M1
Porru, D2
Bavendam, T; Guan, Z; Jones, JS; Kaplan, SA; Roehrborn, CG; Wang, JT1
Wyndaele, JJ2
Rembratt, A1
Bolis, P; Cardozo, L; Salvatore, S; Serati, M; Uccella, S2
Artibani, W; Cavalleri, S; D'Elia, C; Ficarra, V; Galfano, A; Novara, G; Secco, S1
Bavendam, T; Carlsson, M; Guan, Z; Kaplan, SA; Kreder, K; Rovner, ES; Sussman, DO1
Guan, Z; Nitti, VW; Rackley, R; Rovner, ES; Wang, JT1
Brodsky, M; Chapple, CR; Jünemann, KP; Van Kerrebroeck, PE; Wang, JT1
Bachmann, G; Bavendam, T; Guan, Z; Jumadilova, Z; Morrow, JD; Rogers, R; Sun, F1
Azaripour, A; Hajebrahimi, S; Sadeghi-Bazargani, H1
Bavendam, T; Guan, Z; Kaplan, SA; Kraus, SR; Roehrborn, CG; Wang, JT1
MacDiarmid, S; Malhotra, BK; Sandage, BW1
Capo', JP; Chancellor, MB; Forero-Schwanhaeuser, S; Karram, M; Kobashi, K; Laramée, C; Nandy, I; Seifeldin, R; Siami, P; Snyder, JA; Whitmore, K; Zinner, N1
Burcher, E; Chandran, JJ; Christopoulos, A; Mansfield, KJ; Millard, RJ; Mitchelson, FJ; Vaux, KJ1
Brodsky, M; Castro-Diaz, D; Guan, Z; Heesakkers, J; Herschorn, S; Wang, JT1
Abrams, P; Brodsky, M; Chapple, C; Guan, Z; Herschorn, S; Sun, F1
Dmochowski, R1
Speakman, MJ1
Chang, YL; Ko, YJ; Lloyd, LK; Soong, YK; Tseng, LH; Wang, AC1
Bachmann, G; Morrow, JD; Omotosho, T; Rogers, RG; Sun, F1
Malhotra, B; Simon, HU1
Yoshinaga, Y1
Endeshaw, Y; Johnson, TM; Nagamia, Z; Ouslander, JG; Vaughan, CP1
Chancellor, MB; Kuo, HC; Liu, HT1
Brodsky, M; Coyne, KS; Kelleher, CJ; Kopp, Z; Van Kerrebroeck, PE; Wang, JT1
Al-Buheissi, S; Malone-Lee, JG1
Forero-Schwanhaeuser, S; Siami, P; Swift, SE1
Bavendam, T; Berriman, S; Burgio, KL; Guan, Z; Klutke, CG; Sun, F; Wyman, JF1
Axelsen, S; Kulseng-Hansen, S; Mattiasson, A; Milsom, I; Nilsson, CG; Wickstrøm, J1
Iannazzo, S; Pradelli, L1
Bavendam, T; Creanga, DL; Morrow, JD; Nitti, VW; Sand, PK1
Ulahannan, D; Wagg, A1
Bachmann, G; Bavendam, T; Guan, Z; Jumadilova, Z; Morrow, JD; Rogers, RG; Scarpero, H; Sun, F1
Feagins, BA; Jarnagin, BK; Leong, FC; Macdiarmid, SA; Peters, KM; Rosenblatt, PL; Rovner, ES; Shobeiri, SA; Siegel, SW; Tate, SB; Wooldridge, LS1
Carlsson, M; Glasser, DB; Griebling, TL; Kraus, SR; Richter, HE1
Altman, D; Falconer, C; Granath, F; Mattiasson, A1
Gauruder-Burmester, A; Popken, G1
Bolduc, S; Hamel, M; Lamontagne, P; Lebel, S; Moore, K1
Yang, SS1
Jorgensen, TM1
de Jong, TP1
Goode, P; Litman, HJ; Mueller, E; Norton, P; Zimmern, P1
Dolder, C; Olin, JL; Tzefos, M1
Burkart, M; Höfner, K; Jacob, G; Jonas, U2
Fukuhara, S; Hirai, T; Kiuchi, H; Kojimaan, Y; Miyagawa, Y; Nakayama, J; Okuyama, A; Takahashi, T; Takao, T; Tsujimura, A; Uchida, K; Ueda, T; Yamamoto, K1
Yokoyama, O1
Brodsky, M; Carlsson, M; Gong, J; Guan, Z; Herschorn, S; Morrow, JD; Swift, S1
Cardozo, L; Sidhu, M; Thorpe, A; Warner, J1
Mehnert, U; Sauermann, P; Schiffers, M; Schurch, B1
Chung, DE; Kaplan, SA; Staskin, DR; Te, AE1
Akyol, I; Alanbay, I; Atay, V; Ceyhan, ST; Muhcu, M; Mutlu Ercan, C; Sancaktar, M1
Faro, SH; Lebed, B; Lebovitch, S; Mohamed, FB; Moonat, S; Pontari, MA; Ruggieri, MR1
Andersson, AS; Bergqvist, A; Kowalski, J; Peeker, R; Samsioe, G1
Dmochowski, RR; Gomelsky, A1
Abrams, P; Brodsky, M; Chapple, CR; Guan, Z; Herschorn, S; Wang, JT1
Frenkl, TL; Green, S; Reiss, T; Rosenberg, E; Seltzer, O; Zhu, H1
Warner, JL1
Bavendam, T; Berriman, S; Burgio, K; Guan, Z; Klutke, C; Sun, F; Wyman, JF1
Carlsson, M; Foote, JE; Gong, J; Guan, Z; Kaplan, SA; Schneider, T1
Cossons, NH; Darekar, A; Marencak, J; Mills, IW1
Honda, M; Sakakibara, R; Uchiyama, T; Watanabe, M; Yamanishi, T; Yoshida, K1
Chang, TC; Ho, CH; Huang, KH; Lin, HH; Liu, SP; Yu, HJ1
Hui, JH; Lu, FD; Lv, JL; Tang, QN1
Chen, CJ; Deng, YJ; Ge, Z; Guo, YF; Lu, RG; Ma, G; Wang, LX; Zhu, HB1
Chapple, CR; Coyne, KS; Hsieh, R; Margolis, MK; Vats, V1
Chang, TC; Hsiao, SM; Lin, HH; Wu, WY1
Capo', JP; Forero-Schwanhaeuser, S; He, W; Lucente, V1
Chang, HC; Chiu, B; Chung, SD; Kuo, HC; Liao, CH1
Bungay, PJ; Callegari, E; Fenner, KS; Kay, GG; Kempshall, S; LaPerle, JL; Malhotra, B; Michel, MC; Webster, R1
Schröder, A; Thüroff, JW1
Chang, TC; Chen, CH; Hsiao, SM; Lin, HH; Wu, WY; Yu, HJ1
Gan, W; Jia, HT; Li, YF; Luo, MH; Xie, S; Zhang, SF1
Waters, H1
Brubaker, L; Fitzgerald, MP; Fordham, J; Kenton, K; Lowenstein, L; Mueller, ER; Rickey, L; Tulke, M1
Bailen, J; Beals, C; Burke, J; Frenkl, T; Railkar, R; Ruddy, M; Scott, BB; Shore, N; Sutherland, S1
Derpapas, A; Digesu, GA; Fernando, R; Hendricken, C; Khullar, V; Vijaya, G1
Blot, K; Falconer, C; Marschall-Kehrel, D; Michel, MC; Radziszewski, P1
Kaplan, SA1
Bercik, RS; Chen, HW; Thung, SF; Werner, EF1
Chen, Y; Fang, L; Li, C; Liu, C; Liu, J; Mu, L; Sun, L; Wang, Z; Xi, H1
Cody, JD; Ellis, G; Hay-Smith, EJ; Herbison, GP; Madhuvrata, P1
Han, P; Liu, L; Luo, D; Shen, H; Wei, Q1
Chen, YL; Feng, WJ; Zhang, XL1
Lin, Q; Lin, X; Shen, YZ1
Gillespie, JI; Guerard, M; Guilloteau, V; Korstanje, C; Lluel, P; Palea, S1
Arumí, D; Castro-Diaz, D; Lizarraga, I; Miranda, P; Rejas, J; Sanchez-Ballester, F1
Alessandri, F; Candiani, M; Ferrero, S; Leone Roberti Maggiore, U; Origoni, M; Remorgida, V; Salvatore, S; Venturini, PL1
Bavendam, T; Creanga, D; DuBeau, CE; Kraus, SR; Morrow, JD1
Berghmans, B; Moossdorff-Steinhauser, HF1
Dede, FS; Dede, H; Dolen, İ; Sivaslioglu, AA1
Kaufman, RP1
Amarenco, G; Angulo, JC; Boerrigter, P; Cambronero, J; Chapple, C; Drogendijk, T; Høye, K; Khullar, V; Milsom, I; Radziszewski, P; Rechberger, T; Wooning, M1
Chapple, CR; Cummings, J; Dorrepaal, C; Drogendijk, T; Kaplan, SA; Klecka, J; Martin, N; Mitcheson, D1
Cornu, JN; Novara, G1
Chen, HQ; Li, Y; Qi, L; Zeng, F; Zhang, XY1
Jiang, XZ; Xu, C; Xu, ZS; Zhang, NZ; Zhao, HF1
Dmochowski, RR1
Anderson, RU; Barada, JH; Goldberg, RP; Kell, S; MacDiarmid, S; Serels, S1
Bavendam, T; Carlsson, M; Elinoff, V; Eyland, N; Glasser, DB; Roberts, R2
Goepel, M1
Kanofsky, JA; Nitti, VW1
Bavendam, T; Coyne, KS; Jumadilova, Z; Matza, LS; Thompson, C1
Hegde, SS; Michel, MC1
Schaefer, W1
Beck, E; Burkart, M; Goepel, M; Michel, MC; Oelke, M1
Abrams, P; Dmochowski, R; Guan, Z; Marschall-Kehrel, D; Wang, JT1
Bavendam, T; Carlsson, M; Guan, Z; Kaplan, SA; Roehrborn, CG; Rovner, ES1
Girase, P; Jumadilova, Z; Ollendorf, DA; Varadharajan, S1
Babu, R1
Guan, Z; Khullar, V; Wang, JT; Wein, AJ1
Choo, MS; Heo, KO; Lee, KS; Park, JT; Song, C1
Hatanaka, T; Miyata, K; Noguchi, Y; Ohtake, A; Okutsu, H; Saitoh, C; Sasamata, M; Sato, S; Suzuki, M; Ukai, M; Yuyama, H1
Kageyama, A; Oki, T; Takagi, Y; Uchida, S; Yamada, S1
MacDiarmid, S; Rogers, A1
Alberca, R; Barrero, R; Campoy, P; Cayuela, A; Mir, P; Pena, JM1
Subramonian, K; Young, JG1
Amarshi, N; Bell, WA1
Chapple, C1
Carlsson, M; Guan, Z; Kraus, SR; Sussman, DO1
Bertozzi, R; Cipriani, S; Colli, E; Meschia, M; Montorsi, F; Olivieri, L; Parazzini, F1
Chancellor, MB; de Miguel, F1
Newman, DK; Page, SA; Rosenberg, MT; Tallman, CT1
Carlsson, M; Dmochowski, R; Guan, Z; Kreder, K; MacDiarmid, S1
Blaivas, JG; Guan, Z; Jones, M; Wang, JT; Weiss, JP1
Bolodeoku, J; Chapple, CR; Fianu-Jonsson, A; Indig, M; Khullar, V; Mistry, A; Rosa, J; Scarpa, RM; Wright, DM1
Bolge, SC; Chen, A; McDonnell, DD; Wan, GJ1
Christoph, F; Kempkensteffen, C; Miller, K; Moschkowitsch, A; Schostak, M; Schrader, M1
Brodsky, M; Chapple, C; Forst, HT; Haag-Molkenteller, C; Massow, U; Tubaro, A; Van Kerrebroeck, P; Wang, J1
Berglund, L; Brundin, L; Ehren, I; Farrelly, E; Hultling, C; Lafolie, P; Volz, D1
Bolodeoku, J; Cardozo, L; Robinson, D; Terpstra, G1
Bolis, P; Cromi, A; Ghezzi, F; Salvatore, S; Serati, M; Uccella, S1
Akino, H; Aoki, Y; Ito, H; Matsuta, Y; Miwa, Y; Nakai, M; Oyama, N; Tanase, K; Yokoyama, O; Yusup, A1
Roumeguère, T1
Kuo, HC1
Bolis, P; Cardozo, L; Cromi, A; Khullar, V; Salvatore, S; Serati, M; Uccella, S1
Olshansky, B; Serra, DB1
Davila, GW1
Hilas, O; Lam, S1
Bolis, P; Digesu, GA; Khullar, V; Salvatore, S; Serati, M; Triacca, P; Uccella, S1
Choo, MS; Doo, CK; Lee, KS1
Arai, Y; Chancellor, MB; Kaiho, Y; Kwon, DD; Nishiguchi, J; Snyder, PB; Yoshimura, N1
Hasuike, N; Maruyama, S; Suzuki, K; Yamada, S1
Andrews, CN; Bharucha, AE; Guan, Z; Seide, B; Zinsmeister, AR1
Bolis, P; Salvatore, S; Serati, M1
Marshall, T; Noe, L; Rasouliyan, L; Seifeldin, R; Zinner, N1
Ariely, R; D'Souza, AO; Doyle, J; Miller, LA; Smith, MJ1
Brodsky, M; Carlsson, M; Coyne, KS; Deng, DY; Elinoff, V; Glasser, DB; Gordon, DA; Jumadilova, Z1
Culley, EJ; Thomas, L1
Chancellor, MB; Chuang, YC; Thomas, CA; Tyagi, P; Tyagi, S; Yoshimura, N1

Reviews

30 review(s) available for phenylpropanolamine and Bladder, Overactive

ArticleYear
Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies.
    International journal of clinical practice, 2013, Volume: 67, Issue:7

    Topics: Acetanilides; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Clinical Trials, Phase III as Topic; Cresols; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Muscarinic Antagonists; Phenylpropanolamine; Randomized Controlled Trials as Topic; Thiazoles; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Urological Agents; Young Adult

2013
Tolterodine for the treatment of urge urinary incontinence.
    Expert opinion on pharmacotherapy, 2013, Volume: 14, Issue:14

    Topics: Benzhydryl Compounds; Cresols; Humans; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Urological Agents

2013
Cost effectiveness of fesoterodine and tolterodine for the treatment of overactive bladder with urge urinary incontinence in Spain and Finland.
    Clinical drug investigation, 2014, Volume: 34, Issue:5

    Topics: Benzhydryl Compounds; Cost-Benefit Analysis; Cresols; Finland; Humans; Phenylpropanolamine; Spain; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Incontinence, Urge

2014
The role of mirabegron in overactive bladder: a systematic review and meta-analysis.
    Urologia internationalis, 2014, Volume: 93, Issue:3

    Topics: Acetanilides; Benzhydryl Compounds; Cresols; Humans; Muscarinic Antagonists; Odds Ratio; Phenylpropanolamine; Prospective Studies; Research Design; Software; Surveys and Questionnaires; Thiazoles; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Urination; Urological Agents

2014
Tolterodine extended release in the treatment of male OAB/storage LUTS: a systematic review.
    BMC urology, 2014, Oct-27, Volume: 14

    Topics: Adrenergic alpha-Antagonists; Benzhydryl Compounds; Constipation; Cresols; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents; Xerostomia

2014
[Comparisons of therapeutic efficacy and safety of solifenacin versus tolterodine in patients with overactive bladder: a meta-analysis of outcomes].
    Zhonghua yi xue za zhi, 2014, Aug-13, Volume: 94, Issue:30

    Topics: Benzhydryl Compounds; Constipation; Cresols; Humans; Phenylpropanolamine; Quinuclidines; Safety; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Xerostomia

2014
A systematic review and meta-analysis of randomized controlled trials with antimuscarinic drugs for overactive bladder.
    European urology, 2008, Volume: 54, Issue:4

    Topics: Benzhydryl Compounds; Cresols; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Randomized Controlled Trials as Topic; Tolterodine Tartrate; Urinary Bladder, Overactive

2008
[Multinational clinical trial in Japan and Korea on detrusitol].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2009, Volume: 129, Issue:2

    Topics: Benzhydryl Compounds; Cresols; Double-Blind Method; Female; Humans; International Cooperation; Japan; Korea; Male; Mandelic Acids; Multicenter Studies as Topic; Muscarinic Antagonists; Phenylpropanolamine; Randomized Controlled Trials as Topic; Tolterodine Tartrate; Urinary Bladder, Overactive

2009
The safety and efficacy of tolterodine extended release in the treatment of overactive bladder in the elderly.
    Clinical interventions in aging, 2009, Volume: 4

    Topics: Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder, Overactive

2009
Tolterodine extended release is well tolerated in older subjects.
    International journal of clinical practice, 2009, Volume: 63, Issue:8

    Topics: Adult; Aged; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Randomized Controlled Trials as Topic; Retrospective Studies; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive

2009
Fesoterodine for the treatment of overactive bladder.
    The Annals of pharmacotherapy, 2009, Volume: 43, Issue:12

    Topics: Animals; Benzhydryl Compounds; Cresols; Humans; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Randomized Controlled Trials as Topic; Tolterodine Tartrate; Urinary Bladder, Overactive

2009
New strategies for medical management of overactive bladder in children.
    Current opinion in urology, 2010, Volume: 20, Issue:4

    Topics: Benzhydryl Compounds; Benzilates; Botulinum Toxins; Child; Cresols; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Quinuclidines; Receptors, Muscarinic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive; Urination

2010
Which anticholinergic drug for overactive bladder symptoms in adults.
    The Cochrane database of systematic reviews, 2012, Jan-18, Volume: 1

    Topics: Adult; Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Humans; Mandelic Acids; Phenylpropanolamine; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Incontinence

2012
Solifenacin for overactive bladder: a systematic review and meta-analysis.
    International urogynecology journal, 2012, Volume: 23, Issue:8

    Topics: Benzhydryl Compounds; Cresols; Dose-Response Relationship, Drug; Humans; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive

2012
Pharmacokinetics and toxicity of antimuscarinic drugs for overactive bladder treatment in females.
    Expert opinion on drug metabolism & toxicology, 2012, Volume: 8, Issue:11

    Topics: Benzhydryl Compounds; Benzilates; Benzofurans; Chronic Disease; Cresols; Drug Combinations; Female; Humans; Imidazoles; Mandelic Acids; Muscarinic Antagonists; Nocturia; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Incontinence

2012
Effects of percutaneous tibial nerve stimulation on adult patients with overactive bladder syndrome: a systematic review.
    Neurourology and urodynamics, 2013, Volume: 32, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cholinergic Antagonists; Clinical Trials as Topic; Cresols; Evidence-Based Medicine; Female; Humans; Male; Middle Aged; Nocturnal Enuresis; Phenylpropanolamine; Tibial Nerve; Time Factors; Tolterodine Tartrate; Transcutaneous Electric Nerve Stimulation; Treatment Outcome; Urinary Bladder; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Urodynamics; Young Adult

2013
[Safety of solifenacin and tolterodine in the treatment of overactive bladder: a meta-analysis].
    Zhonghua yi xue za zhi, 2012, Dec-25, Volume: 92, Issue:48

    Topics: Benzhydryl Compounds; Cresols; Humans; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive

2012
The puzzle of overactive bladder: controversies, inconsistencies, and insights.
    International urogynecology journal and pelvic floor dysfunction, 2006, Volume: 17, Issue:6

    Topics: Animals; Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Female; Humans; Mandelic Acids; Muscarinic Antagonists; Muscle Contraction; Parasympatholytics; Patient Compliance; Phenylpropanolamine; Quality of Life; Tolterodine Tartrate; Urinary Bladder; Urinary Bladder, Overactive

2006
Tolterodine for treatment of overactive bladder.
    The Urologic clinics of North America, 2006, Volume: 33, Issue:4

    Topics: Benzhydryl Compounds; Clinical Trials as Topic; Cresols; Delayed-Action Preparations; Humans; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder, Overactive

2006
Treatment of the overactive bladder syndrome with muscarinic receptor antagonists: a matter of metabolites?
    Naunyn-Schmiedeberg's archives of pharmacology, 2006, Volume: 374, Issue:2

    Topics: Benzhydryl Compounds; Benzilates; Benzofurans; Cresols; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Parasympatholytics; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive

2006
Male overactive bladder: the role of urodynamics and anticholinergics.
    Current urology reports, 2007, Volume: 8, Issue:1

    Topics: Adult; Aged; Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Cystoscopy; Follow-Up Studies; Humans; Male; Mandelic Acids; Middle Aged; Multicenter Studies as Topic; Phenylpropanolamine; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder Neck Obstruction; Urinary Bladder, Overactive; Urodynamics

2007
Number of daytime micturitions and volume voided per micturition in the evaluation of efficacy of drugs for overactive bladder: findings from randomized clinical trials.
    European urology, 2007, Volume: 52, Issue:2

    Topics: Benzhydryl Compounds; Cresols; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive; Urination

2007
Treatment of overactive bladder: selective use of anticholinergic agents with low drug-drug interaction potential.
    Geriatrics, 2007, Volume: 62, Issue:5

    Topics: Benzhydryl Compounds; Benzilates; Cholinergic Antagonists; Cresols; Cytochrome P-450 Enzyme System; Drug Interactions; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder, Overactive

2007
Overactive bladder: recognition requires vigilance for symptoms.
    Cleveland Clinic journal of medicine, 2007, Volume: 74 Suppl 3

    Topics: Benzhydryl Compounds; Cost of Illness; Cresols; Female; Humans; Male; Mandelic Acids; Mass Screening; Muscarinic Antagonists; Phenylpropanolamine; Prevalence; Quality of Life; Tolterodine Tartrate; Urinary Bladder, Overactive

2007
Update on drugs for overactive bladder syndrome.
    Drug and therapeutics bulletin, 2007, Volume: 45, Issue:6

    Topics: Benzhydryl Compounds; Benzilates; Benzofurans; Cholinergic Antagonists; Cresols; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive

2007
Patient satisfaction with extended release tolterodine or oxybutynin in overactive bladder.
    Current medical research and opinion, 2007, Volume: 23, Issue:8

    Topics: Aged; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Female; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Patient Compliance; Patient Satisfaction; Phenylpropanolamine; Quality of Life; Tolterodine Tartrate; Urinary Bladder, Overactive

2007
Transdermal oxybutynin in the treatment of overactive bladder.
    Clinical interventions in aging, 2006, Volume: 1, Issue:2

    Topics: Administration, Topical; Benzhydryl Compounds; Cresols; Humans; Mandelic Acids; Parasympatholytics; Patient Satisfaction; Phenylpropanolamine; Technology, Pharmaceutical; Tolterodine Tartrate; Urinary Bladder, Overactive

2006
Pharmacologic management of overactive bladder.
    Clinical interventions in aging, 2007, Volume: 2, Issue:3

    Topics: Benzhydryl Compounds; Benzofurans; Cresols; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive

2007
Tolterodine for the treatment of overactive bladder.
    Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:7

    Topics: Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Female; Humans; Male; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Randomized Controlled Trials as Topic; Tolterodine Tartrate; Urinary Bladder, Overactive

2008
Overactive bladder disease: the urge for better therapies.
    Journal of managed care pharmacy : JMCP, 2008, Volume: 14, Issue:4

    Topics: Benzhydryl Compounds; Benzilates; Cresols; Delayed-Action Preparations; Female; Humans; Male; Muscarinic Antagonists; Nortropanes; Parasympatholytics; Patient Compliance; Phenylpropanolamine; Randomized Controlled Trials as Topic; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive

2008

Trials

82 trial(s) available for phenylpropanolamine and Bladder, Overactive

ArticleYear
Efficacy of fesoterodine compared with extended-release tolterodine in men and women with overactive bladder.
    BJU international, 2013, Volume: 112, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Tolterodine Tartrate; Urinary Bladder, Overactive; Young Adult

2013
Phase II study on the efficacy and safety of the EP1 receptor antagonist ONO-8539 for nonneurogenic overactive bladder syndrome.
    The Journal of urology, 2014, Volume: 191, Issue:1

    Topics: Adult; Aged; Benzhydryl Compounds; Cresols; Double-Blind Method; Female; Humans; Male; Middle Aged; Phenylpropanolamine; Receptors, Prostaglandin E, EP1 Subtype; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents

2014
[Cardura monotherapy versus combination therapy of cardura and tolterodine L-tartrate tablets for II° ? benign prostatic hyperplasia with overactive bladder].
    Zhonghua nan ke xue = National journal of andrology, 2013, Volume: 19, Issue:12

    Topics: Aged; Benzhydryl Compounds; Cresols; Doxazosin; Drug Therapy, Combination; Humans; Male; Middle Aged; Phenylpropanolamine; Prostatic Hyperplasia; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive

2013
Phase III, randomised, double-blind, placebo-controlled study of the β3-adrenoceptor agonist mirabegron, 50 mg once daily, in Japanese patients with overactive bladder.
    BJU international, 2014, Volume: 113, Issue:6

    Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Aged; Asian People; Benzhydryl Compounds; Cresols; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Thiazoles; Tolterodine Tartrate; Urinary Bladder, Overactive

2014
Do patient characteristics predict responsiveness to treatment of overactive bladder with antimuscarinic agents?
    Urology, 2014, Volume: 83, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Double-Blind Method; Female; Humans; Logistic Models; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prognosis; Tolterodine Tartrate; Urinary Bladder, Overactive

2014
Web-based trial to evaluate the efficacy and safety of tolterodine ER 4 mg in participants with overactive bladder: REMOTE trial.
    Contemporary clinical trials, 2014, Volume: 38, Issue:2

    Topics: Adult; Benzhydryl Compounds; Cell Phone; Cresols; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Internet; Middle Aged; Phenylpropanolamine; Research Design; Tolterodine Tartrate; Urinary Bladder, Overactive; Urological Agents

2014
[Treatment of overactive bladder in older women increased doses of antimuscarinic drugs safe and effective alternative to existing methods].
    Advances in gerontology = Uspekhi gerontologii, 2014, Volume: 27, Issue:1

    Topics: Aged; Benzhydryl Compounds; Benzilates; Cresols; Dose-Response Relationship, Drug; Double-Blind Method; Drug Monitoring; Drug Synergism; Drug Therapy, Combination; Female; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Urodynamics

2014
Mirabegron 50 mg once-daily for the treatment of symptoms of overactive bladder: an overview of efficacy and tolerability over 12 weeks and 1 year.
    International journal of urology : official journal of the Japanese Urological Association, 2014, Volume: 21, Issue:10

    Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Aged; Benzhydryl Compounds; Cresols; Double-Blind Method; Drug Administration Schedule; Female; Headache; Humans; Hypertension; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Thiazoles; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Retention; Urinary Tract Infections; Urination; Xerostomia

2014
Combination of sacral neuromodulation and tolterodine for treatment of idiopathic overactive bladder in women: a clinical trial.
    Urology journal, 2014, Sep-06, Volume: 11, Issue:4

    Topics: Adult; Aged; Anxiety; Benzhydryl Compounds; Combined Modality Therapy; Cresols; Depression; Electric Stimulation Therapy; Female; Humans; Lumbosacral Plexus; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Psychiatric Status Rating Scales; Tolterodine Tartrate; Urinary Bladder, Overactive; Urine

2014
Posterior tibial nerve stimulation for treating neurologic bladder in women: a randomized clinical trial.
    Acta medica Iranica, 2014, Volume: 52, Issue:11

    Topics: Adult; Benzhydryl Compounds; Cresols; Electric Stimulation Therapy; Female; Humans; Middle Aged; Phenylpropanolamine; Rectum; Tibial Nerve; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Neurogenic; Urinary Bladder, Overactive

2014
Cost effectiveness of mirabegron compared with tolterodine extended release for the treatment of adults with overactive bladder in the United Kingdom.
    Clinical drug investigation, 2015, Volume: 35, Issue:2

    Topics: Acetanilides; Adult; Benzhydryl Compounds; Cost-Benefit Analysis; Cresols; Double-Blind Method; Humans; Phenylpropanolamine; Quality of Life; Thiazoles; Tolterodine Tartrate; United Kingdom; Urinary Bladder, Overactive; Urological Agents

2015
Prominent complaint: a guide to medical therapy of overactive bladder syndrome in older women.
    Acta medica Iranica, 2015, Volume: 53, Issue:2

    Topics: Aged; Benzhydryl Compounds; Cresols; Double-Blind Method; Female; Humans; Iran; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Syndrome; Tolterodine Tartrate; Urinary Bladder, Overactive

2015
Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
    BJU international, 2008, Volume: 102, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prostatic Hyperplasia; Prostatism; Quality of Life; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive

2008
A cost-utility analysis of once daily solifenacin compared to tolterodine in the treatment of overactive bladder syndrome.
    Current medical research and opinion, 2008, Volume: 24, Issue:8

    Topics: Benzhydryl Compounds; Cost-Benefit Analysis; Cresols; Double-Blind Method; Humans; Markov Chains; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive

2008
Is there a synergistic effect of topical oestrogens when administered with antimuscarinics in the treatment of symptomatic detrusor overactivity?
    European urology, 2009, Volume: 55, Issue:3

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Drug Synergism; Drug Therapy, Combination; Estriol; Estrogens; Female; Humans; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Tolterodine Tartrate; Urinary Bladder, Overactive

2009
Effect of tolterodine extended release with or without tamsulosin on measures of urgency and patient reported outcomes in men with lower urinary tract symptoms.
    The Journal of urology, 2008, Volume: 180, Issue:3

    Topics: Adrenergic alpha-Antagonists; Adult; Analysis of Variance; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Patient Satisfaction; Phenylpropanolamine; Prostatic Hyperplasia; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge

2008
Tolterodine extended release is efficacious in continent and incontinent subjects with overactive bladder.
    Urology, 2008, Volume: 72, Issue:3

    Topics: Aged; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Placebos; Time Factors; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Urination

2008
Comparison of fesoterodine and tolterodine in patients with overactive bladder.
    BJU international, 2008, Volume: 102, Issue:9

    Topics: Adolescent; Adult; Aged; Benzhydryl Compounds; Cresols; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Surveys and Questionnaires; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urination Disorders; Urodynamics; Young Adult

2008
Efficacy of tolterodine on overactive bladder symptoms and sexual and emotional quality of life in sexually active women.
    International urogynecology journal and pelvic floor dysfunction, 2008, Volume: 19, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Double-Blind Method; Emotions; Female; Follow-Up Studies; Humans; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Sexuality; Surveys and Questionnaires; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Young Adult

2008
Tolterodine immediate release improves sexual function in women with overactive bladder.
    The journal of sexual medicine, 2008, Volume: 5, Issue:12

    Topics: Adult; Arousal; Benzhydryl Compounds; Cresols; Female; Humans; Libido; Middle Aged; Muscarinic Antagonists; Orgasm; Phenylpropanolamine; Quality of Life; Sexual Behavior; Sexual Dysfunction, Physiological; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Incontinence; Young Adult

2008
Effects of serum PSA on efficacy of tolterodine extended release with or without tamsulosin in men with LUTS, including OAB.
    Urology, 2008, Volume: 72, Issue:5

    Topics: Adrenergic alpha-Antagonists; Aged; Benzhydryl Compounds; Cohort Studies; Cresols; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Predictive Value of Tests; Prostate-Specific Antigen; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urination Disorders

2008
Efficacy of solifenacin in patients previously treated with tolterodine extended release 4 mg: results of a 12-week, multicenter, open-label, flexible-dose study.
    Clinical therapeutics, 2008, Volume: 30, Issue:10

    Topics: Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive

2008
Effects of tolterodine extended release on patient perception of bladder condition and overactive bladder symptoms*.
    Current medical research and opinion, 2008, Volume: 24, Issue:12

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Canada; Cresols; Delayed-Action Preparations; Europe; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Surveys and Questionnaires; Time Factors; Tolterodine Tartrate; Turkey; Urinary Bladder; Urinary Bladder, Overactive

2008
Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with alpha-blockers.
    European urology, 2009, Volume: 56, Issue:3

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Double-Blind Method; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Prostatism; Tolterodine Tartrate; Urinary Bladder, Overactive

2009
Randomized comparison of tolterodine with vaginal estrogen cream versus tolterodine alone for the treatment of postmenopausal women with overactive bladder syndrome.
    Neurourology and urodynamics, 2009, Volume: 28, Issue:1

    Topics: Administration, Intravaginal; Aged; Benzhydryl Compounds; Cresols; Drug Therapy, Combination; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Postmenopause; Prospective Studies; Quality of Life; Surveys and Questionnaires; Syndrome; Time Factors; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urodynamics; Vaginal Creams, Foams, and Jellies

2009
Continued symptom improvement in sexually active women with overactive bladder and urgency urinary incontinence treated with tolterodine ER for 6 months.
    International urogynecology journal and pelvic floor dysfunction, 2009, Volume: 20, Issue:4

    Topics: Adult; Anxiety; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Depression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Health Surveys; Humans; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Sexual Behavior; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge

2009
The pharmacokinetic profile of fesoterodine: similarities and differences to tolterodine.
    Swiss medical weekly, 2009, Mar-07, Volume: 139, Issue:9-10

    Topics: Administration, Oral; Adolescent; Adult; Benzhydryl Compounds; Chromatography, Liquid; Cresols; Cross-Over Studies; Gas Chromatography-Mass Spectrometry; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Reference Values; Tolterodine Tartrate; Urinary Bladder, Overactive; Young Adult

2009
Does urodynamic verification of overactive bladder determine treatment success? Results from a randomized placebo-controlled study.
    BJU international, 2009, Volume: 103, Issue:7

    Topics: Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Urodynamics

2009
Diary and patient-reported outcomes in patients with severe overactive bladder switching from tolterodine extended release 4 mg/day to solifenacin treatment: An open-label, flexible-dosing, multicentre study.
    Clinical drug investigation, 2009, Volume: 29, Issue:5

    Topics: Aged; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Quinuclidines; Severity of Illness Index; Solifenacin Succinate; Surveys and Questionnaires; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive

2009
Efficacy and tolerability of fesoterodine in women with overactive bladder.
    International urogynecology journal and pelvic floor dysfunction, 2009, Volume: 20, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Constipation; Cresols; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive

2009
Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.
    Current medical research and opinion, 2009, Volume: 25, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Middle Aged; Muscarinic Antagonists; Patient Satisfaction; Phenylpropanolamine; Placebos; Sexual Behavior; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Young Adult

2009
Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial.
    The Journal of urology, 2009, Volume: 182, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Electric Stimulation Therapy; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Tibial Nerve; Tolterodine Tartrate; Urinary Bladder, Overactive; Young Adult

2009
[Follow-up at 24 months after treatment of overactive bladder with 0.2 % sodium chondroitin sulfate].
    Aktuelle Urologie, 2009, Volume: 40, Issue:6

    Topics: Administration, Intravesical; Administration, Oral; Adult; Aged; Benzhydryl Compounds; Cholinergic Antagonists; Chondroitin Sulfates; Combined Modality Therapy; Cresols; Female; Follow-Up Studies; Humans; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Quality of Life; Tolterodine Tartrate; Urinary Bladder, Overactive; Urodynamics

2009
Double anticholinergic therapy for refractory overactive bladder.
    The Journal of urology, 2009, Volume: 182, Issue:4 Suppl

    Topics: Adolescent; Algorithms; Benzhydryl Compounds; Child; Cresols; Drug Therapy, Combination; Female; Humans; Male; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Tolterodine Tartrate; Urinary Bladder, Overactive

2009
Effect of fluid management on fluid intake and urge incontinence in a trial for overactive bladder in women.
    BJU international, 2010, Volume: 105, Issue:12

    Topics: Behavior Therapy; Benzhydryl Compounds; Combined Modality Therapy; Cresols; Female; Humans; Middle Aged; Muscarinic Antagonists; Patient Satisfaction; Phenylpropanolamine; Prospective Studies; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Urodynamics

2010
Comparison of fesoterodine and tolterodine extended release for the treatment of overactive bladder: a head-to-head placebo-controlled trial.
    BJU international, 2010, Volume: 105, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Epidemiologic Methods; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Patient Satisfaction; Phenylpropanolamine; Quality of Life; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Young Adult

2010
The effect of tolterodine 4 and 8 mg on the heart rate variability in healthy subjects.
    World journal of urology, 2010, Volume: 28, Issue:5

    Topics: Administration, Oral; Adult; Benzhydryl Compounds; Cresols; Dose-Response Relationship, Drug; Electrocardiography; Female; Heart Rate; Humans; Muscarinic Antagonists; Phenylpropanolamine; Supine Position; Tolterodine Tartrate; Urinary Bladder, Overactive

2010
The outcome of adding peripheral neuromodulation (Stoller afferent neuro-stimulation) to anti-muscarinic therapy in women with severe overactive bladder.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2010, Volume: 26, Issue:10

    Topics: Adult; Benzhydryl Compounds; Combined Modality Therapy; Cresols; Electric Stimulation Therapy; Female; Humans; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Quality of Life; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive

2010
Central nervous system findings on functional magnetic resonance imaging in patients before and after treatment with anticholinergic medication.
    The Journal of urology, 2010, Volume: 183, Issue:5

    Topics: Benzhydryl Compounds; Brain; Cresols; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Placebos; Surveys and Questionnaires; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive

2010
Efficacy and safety of tolterodine extended-release in men with overactive bladder symptoms treated with an α-blocker: effect of baseline prostate-specific antigen concentration.
    BJU international, 2010, Volume: 106, Issue:9

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prostate-Specific Antigen; Prostatic Hyperplasia; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive

2010
A multicenter, double-blind, randomized, placebo controlled trial of a neurokinin-1 receptor antagonist for overactive bladder.
    The Journal of urology, 2010, Volume: 184, Issue:2

    Topics: Benzhydryl Compounds; Cresols; Double-Blind Method; Female; Humans; Isoindoles; Male; Middle Aged; Muscarinic Antagonists; Neurokinin-1 Receptor Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder, Overactive

2010
Effects of combined behavioral intervention and tolterodine on patient-reported outcomes.
    The Canadian journal of urology, 2010, Volume: 17, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Behavior Therapy; Benzhydryl Compounds; Combined Modality Therapy; Cresols; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Patient Satisfaction; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Young Adult

2010
Superior efficacy of fesoterodine over tolterodine extended release with rapid onset: a prospective, head-to-head, placebo-controlled trial.
    BJU international, 2011, Volume: 107, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Epidemiologic Methods; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Young Adult

2011
Investigation of the clinical efficacy and safety of pregabalin alone or combined with tolterodine in female subjects with idiopathic overactive bladder.
    Neurourology and urodynamics, 2011, Volume: 30, Issue:1

    Topics: Adult; Aged; Analgesics; Benzhydryl Compounds; Cresols; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; gamma-Aminobutyric Acid; Humans; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Pregabalin; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urination

2011
Solifenacin and tolterodine are equally effective in the treatment of overactive bladder symptoms.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2010, Volume: 109, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Quinuclidines; Solifenacin Succinate; Taiwan; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Urination

2010
Efficacy of tolterodine for medical treatment of intramural ureteral stone with vesical irritability.
    Urological research, 2011, Volume: 39, Issue:3

    Topics: Adult; Benzhydryl Compounds; Cresols; Female; Humans; Male; Muscarinic Antagonists; Pain; Pain Measurement; Phenylpropanolamine; Retrospective Studies; Tolterodine Tartrate; Treatment Outcome; Ureteral Calculi; Urinary Bladder, Overactive; Watchful Waiting

2011
[Comparisons of efficacy and safety of tolterodine and oxybutynin in children with idiopathic overactive bladder].
    Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 2011, Volume: 13, Issue:1

    Topics: Adolescent; Benzhydryl Compounds; Child; Child, Preschool; Cresols; Female; Humans; Male; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder, Overactive

2011
Changes in urodynamic parameters after tolterodine treatment for female overactive bladder syndrome with or without voiding dysfunction.
    The journal of obstetrics and gynaecology research, 2011, Volume: 37, Issue:5

    Topics: Adult; Aged; Benzhydryl Compounds; Cresols; Female; Humans; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urination Disorders; Urodynamics

2011
The efficacy of additive tolterodine extended release for 1-year in older men with storage symptoms and clinical benign proastatic hyperplasia.
    Neurourology and urodynamics, 2011, Volume: 30, Issue:4

    Topics: Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Humans; International Cooperation; Male; Muscarinic Antagonists; Phenylpropanolamine; Prostatic Hyperplasia; Quality of Life; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Retention

2011
Comparisons of urodynamic effects, therapeutic efficacy and safety of solifenacin versus tolterodine for female overactive bladder syndrome.
    The journal of obstetrics and gynaecology research, 2011, Volume: 37, Issue:8

    Topics: Adult; Aged; Benzhydryl Compounds; Cresols; Female; Humans; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive; Urodynamics

2011
[Tolterodine tartrate combined with alpha-receptor blocker for benign prostatic hyperplasia with detrusor overactivity].
    Zhonghua nan ke xue = National journal of andrology, 2011, Volume: 17, Issue:4

    Topics: Adrenergic alpha-Antagonists; Aged; Benzhydryl Compounds; Cresols; Humans; Male; Muscarinic Antagonists; Phenylpropanolamine; Prostatic Hyperplasia; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive

2011
Evaluation of an experimental urodynamic platform to identify treatment effects: a randomized, placebo-controlled, crossover study in patients with overactive bladder.
    Neurourology and urodynamics, 2012, Volume: 31, Issue:1

    Topics: Adult; Aged; Benzhydryl Compounds; Compliance; Cresols; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Reproducibility of Results; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder; Urinary Bladder, Overactive; Urination; Urodynamics

2012
Antimuscarinic effects on current perception threshold: a prospective placebo control study.
    Neurourology and urodynamics, 2012, Volume: 31, Issue:1

    Topics: Adult; Aged; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Double-Blind Method; Electric Stimulation; Female; Humans; Middle Aged; Muscarinic Antagonists; Nerve Fibers, Unmyelinated; Neurons, Afferent; Perception; Phenylpropanolamine; Prospective Studies; Tolterodine Tartrate; Treatment Outcome; Urethra; Urinary Bladder; Urinary Bladder, Overactive

2012
Unexpected frequent hepatotoxicity of a prescription drug, flupirtine, marketed for about 30 years.
    British journal of clinical pharmacology, 2012, Volume: 73, Issue:5

    Topics: Aged; Aminopyridines; Analgesics; Benzhydryl Compounds; Chemical and Drug Induced Liver Injury; Cresols; Double-Blind Method; Female; Humans; Liver; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Syndrome; Tolterodine Tartrate; Urinary Bladder, Overactive

2012
[Parkinson's disease combined with overactive bladder syndrome treated with acupuncture and medication].
    Zhongguo zhen jiu = Chinese acupuncture & moxibustion, 2012, Volume: 32, Issue:3

    Topics: Adult; Aged; Benzhydryl Compounds; Combined Modality Therapy; Cresols; Electroacupuncture; Female; Humans; Male; Middle Aged; Parkinson Disease; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder, Overactive

2012
[Overactive bladder after transurethral resection of prostate treated with electroacupuncture therapy and tolterodine].
    Zhongguo zhen jiu = Chinese acupuncture & moxibustion, 2012, Volume: 32, Issue:5

    Topics: Aged; Aged, 80 and over; Benzhydryl Compounds; Combined Modality Therapy; Cresols; Electroacupuncture; Humans; Male; Middle Aged; Phenylpropanolamine; Postoperative Complications; Prostate; Tolterodine Tartrate; Transurethral Resection of Prostate; Urinary Bladder, Overactive

2012
What is the success of drug treatment in urge urinary incontinence? What should be measured?
    Archives of gynecology and obstetrics, 2013, Volume: 287, Issue:3

    Topics: Adult; Benzhydryl Compounds; Benzilates; Cresols; Female; Humans; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Quality of Life; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Urodynamics

2013
Efficacy and tolerability of mirabegron, a β(3)-adrenoceptor agonist, in patients with overactive bladder: results from a randomised European-Australian phase 3 trial.
    European urology, 2013, Volume: 63, Issue:2

    Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Aged; Australia; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Double-Blind Method; Europe; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Single-Blind Method; Surveys and Questionnaires; Thiazoles; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Urination

2013
Randomized double-blind, active-controlled phase 3 study to assess 12-month safety and efficacy of mirabegron, a β(3)-adrenoceptor agonist, in overactive bladder.
    European urology, 2013, Volume: 63, Issue:2

    Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Aged; Benzhydryl Compounds; Constipation; Cresols; Delayed-Action Preparations; Double-Blind Method; Female; Headache; Humans; Hypertension; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Single-Blind Method; Thiazoles; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Urinary Retention; Xerostomia

2013
Comparative study of pelvic floor biofeedback training and tolterodine for treatment of detrusor after-contraction in posturination dribbling in children.
    The Journal of international medical research, 2012, Volume: 40, Issue:6

    Topics: Adolescent; Benzhydryl Compounds; Biofeedback, Psychology; Child; Cresols; Female; Humans; Male; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; Pelvic Floor; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder; Urinary Bladder, Overactive; Urinary Incontinence; Urodynamics

2012
Effectiveness and tolerability of extended-release oxybutynin vs extended-release tolterodine in women with or without prior anticholinergic treatment for overactive bladder.
    International urogynecology journal and pelvic floor dysfunction, 2006, Volume: 17, Issue:5

    Topics: Adult; Aged; Benzhydryl Compounds; Cresols; Demography; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Patient Dropouts; Patient Participation; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge

2006
Symptom-specific efficacy of tolterodine extended release in patients with overactive bladder: the IMPACT trial.
    International journal of clinical practice, 2006, Volume: 60, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder, Overactive

2006
Tolterodine extended release improves patient-reported outcomes in overactive bladder: results from the IMPACT trial.
    International journal of clinical practice, 2006, Volume: 60, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Patient Satisfaction; Phenylpropanolamine; Quality of Life; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence

2006
The responsiveness of the OAB-q among OAB patient subgroups.
    Neurourology and urodynamics, 2007, Volume: 26, Issue:2

    Topics: Adaptation, Psychological; Aged; Benzhydryl Compounds; Cresols; Female; Humans; Male; Medical Records; Middle Aged; Muscarinic Agonists; Phenylpropanolamine; Sex Characteristics; Surveys and Questionnaires; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Urination

2007
Relationships among symptoms, bother, and treatment satisfaction in overactive bladder patients.
    Neurourology and urodynamics, 2007, Volume: 26, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cluster Analysis; Cresols; Delayed-Action Preparations; Factor Analysis, Statistical; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Nocturia; Patient Satisfaction; Phenylpropanolamine; Principal Component Analysis; Statistics, Nonparametric; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence

2007
Efficacy and tolerability of tolterodine extended release in male and female patients with overactive bladder.
    European urology, 2007, Volume: 51, Issue:4

    Topics: Benzhydryl Compounds; Cresols; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Single-Blind Method; Tolterodine Tartrate; Urinary Bladder, Overactive

2007
Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial.
    JAMA, 2006, Nov-15, Volume: 296, Issue:19

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Incontinence, Urge

2006
Effectiveness of tolterodine in nonneurogenic voiding dysfunction.
    Indian pediatrics, 2006, Volume: 43, Issue:11

    Topics: Benzhydryl Compounds; Child; Cresols; Delayed-Action Preparations; Enuresis; Female; Humans; Male; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Incontinence, Urge

2006
Achieving continence with antimuscarinic therapy for overactive bladder: effects of baseline incontinence severity and bladder diary duration.
    BJU international, 2007, Volume: 99, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Double-Blind Method; Female; Humans; Male; Medical Records; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Severity of Illness Index; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence

2007
Effects of bladder training and/or tolterodine in female patients with overactive bladder syndrome: a prospective, randomized study.
    Journal of Korean medical science, 2006, Volume: 21, Issue:6

    Topics: Behavior Therapy; Benzhydryl Compounds; Combined Modality Therapy; Cresols; Female; Humans; Middle Aged; Muscarinic Antagonists; Outcome Assessment, Health Care; Phenylpropanolamine; Toilet Training; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive

2006
Onset of efficacy of tolterodine extended release in patients with overactive bladder.
    Current medical research and opinion, 2007, Volume: 23, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Time Factors; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive

2007
The clinical efficacy of tolterodine extended-release is maintained for 24 h in patients with overactive bladder.
    BJU international, 2007, Volume: 100, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Medical Records; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Urodynamics

2007
Age related pathogenesis of nocturia in patients with overactive bladder.
    The Journal of urology, 2007, Volume: 178, Issue:2

    Topics: Age Factors; Aged; Benzhydryl Compounds; Cresols; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Nocturia; Phenylpropanolamine; Polyuria; Retrospective Studies; Sex Factors; Tolterodine Tartrate; Urinary Bladder, Overactive; Urodynamics

2007
Treatment outcomes in the STAR study: a subanalysis of solifenacin 5 mg and tolterodine ER 4 mg.
    European urology, 2007, Volume: 52, Issue:4

    Topics: Aged; Benzhydryl Compounds; Cresols; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Safety; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Stress; Urination

2007
Clinical efficacy, safety, and tolerability of once-daily fesoterodine in subjects with overactive bladder.
    European urology, 2007, Volume: 52, Issue:4

    Topics: Adult; Aged; Benzhydryl Compounds; Cresols; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Patient Selection; Phenylpropanolamine; Safety; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Incontinence; Urination

2007
Efficacy and impact of botulinum toxin A on quality of life in patients with neurogenic detrusor overactivity: a randomised, placebo-controlled, double-blind study.
    Scandinavian journal of urology and nephrology, 2007, Volume: 41, Issue:4

    Topics: Administration, Oral; Benzhydryl Compounds; Botulinum Toxins, Type A; Cresols; Double-Blind Method; Female; Humans; Male; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Tolterodine Tartrate; Urinary Bladder, Overactive

2007
A randomized double-blind placebo-controlled multicentre study to explore the efficacy and safety of tamsulosin and tolterodine in women with overactive bladder syndrome.
    BJU international, 2007, Volume: 100, Issue:4

    Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Single-Blind Method; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urodynamics

2007
Safety and efficacy of tolterodine extended release in men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia.
    World journal of urology, 2007, Volume: 25, Issue:6

    Topics: Aged; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prostatic Hyperplasia; Quality of Life; Regression Analysis; Severity of Illness Index; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Urodynamics

2007
Satisfaction with tolterodine: assessing symptom-specific patient-reported goal achievement in the treatment of overactive bladder in female patients (STARGATE study).
    International journal of clinical practice, 2008, Volume: 62, Issue:2

    Topics: Adult; Aged; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Female; Humans; Middle Aged; Muscarinic Antagonists; Patient Satisfaction; Phenylpropanolamine; Prospective Studies; Severity of Illness Index; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive

2008
Effect of tolterodine on gastrointestinal transit and bowel habits in healthy subjects.
    Neurogastroenterology and motility, 2008, Volume: 20, Issue:6

    Topics: Adult; Benzhydryl Compounds; Constipation; Cresols; Defecation; Double-Blind Method; Female; Gastrointestinal Motility; Gastrointestinal Transit; Humans; Male; Middle Aged; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder, Overactive

2008
Impact of solifenacin on resource utilization, work productivity and health utility in overactive bladder patients switching from tolterodine ER.
    Current medical research and opinion, 2008, Volume: 24, Issue:6

    Topics: Activities of Daily Living; Aged; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Female; Health Services; Humans; Male; Middle Aged; Muscarinic Antagonists; Outcome Assessment, Health Care; Patient Acceptance of Health Care; Phenylpropanolamine; Quality of Life; Quinuclidines; Solifenacin Succinate; Surveys and Questionnaires; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive

2008
Relationships between improvements in symptoms and patient assessments of bladder condition, symptom bother and health-related quality of life in patients with overactive bladder treated with tolterodine.
    International journal of clinical practice, 2008, Volume: 62, Issue:6

    Topics: Benzhydryl Compounds; Cresols; Female; Health Status; Humans; Male; Middle Aged; Muscarinic Antagonists; Patient Satisfaction; Phenylpropanolamine; Quality of Life; Surveys and Questionnaires; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive

2008

Other Studies

85 other study(ies) available for phenylpropanolamine and Bladder, Overactive

ArticleYear
Patient Perception of Bladder Condition after Treatment with Solifenacin and Tolterodine in Overactive Bladder Patients.
    Journal of Nepal Health Research Council, 2023, Mar-10, Volume: 20, Issue:3

    Topics: Benzhydryl Compounds; Cresols; Cross-Sectional Studies; Humans; Nepal; Perception; Phenylpropanolamine; Solifenacin Succinate; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder; Urinary Bladder Diseases; Urinary Bladder, Overactive

2023
Re: Tolterodine ER Reduced Increased Bladder Wall Thickness in Women with Overactive Bladder. A Randomized, Placebo-Controlled, Double-Blind, Parallel Group Study.
    The Journal of urology, 2019, Volume: 201, Issue:4

    Topics: Cresols; Double-Blind Method; Female; Humans; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder, Overactive

2019
[A role of fesoterodine in treatment of overactive bladder].
    Urologiia (Moscow, Russia : 1999), 2018, Issue:6

    Topics: Benzhydryl Compounds; Cresols; Humans; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive

2018
Understanding the effects on HR-QoL of treatment for overactive bladder: a detailed analysis of EQ-5D clinical trial data for mirabegron.
    Journal of medical economics, 2013, Volume: 16, Issue:7

    Topics: Acetanilides; Analysis of Variance; Benzhydryl Compounds; Clinical Trials, Phase III as Topic; Cresols; Data Interpretation, Statistical; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Psychometrics; Quality-Adjusted Life Years; Sickness Impact Profile; Thiazoles; Tolterodine Tartrate; Urinary Bladder, Overactive

2013
Adherence, persistence and switch rates for anticholinergic drugs used for overactive bladder in women: data from the Norwegian Prescription Database.
    Acta obstetricia et gynecologica Scandinavica, 2013, Volume: 92, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Benzofurans; Cholinergic Antagonists; Cresols; Databases, Pharmaceutical; Drug Substitution; Female; Follow-Up Studies; Humans; Medication Adherence; Middle Aged; Norway; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive; Young Adult

2013
Flexible dose fesoterodine in the treatment of overactive bladder (OAB).
    BJU international, 2013, Volume: 112, Issue:3

    Topics: Benzhydryl Compounds; Cresols; Female; Humans; Male; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder, Overactive

2013
Cost-effectiveness analysis of solifenacin versus oxybutynin immediate-release in the treatment of patients with overactive bladder in the United Kingdom.
    Journal of medical economics, 2013, Volume: 16, Issue:10

    Topics: Benzhydryl Compounds; Cohort Studies; Cost-Benefit Analysis; Cresols; Humans; Incontinence Pads; Mandelic Acids; Markov Chains; Medication Adherence; Models, Economic; Muscarinic Antagonists; Patient Dropouts; Phenylpropanolamine; Quality-Adjusted Life Years; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; United Kingdom; Urinary Bladder, Overactive; Urinary Incontinence

2013
Preparation, characterization and pharmacological evaluation of tolterodine hydrogels for the treatment of overactive bladder.
    International journal of pharmaceutics, 2013, Sep-15, Volume: 454, Issue:1

    Topics: Acrylic Resins; Administration, Cutaneous; Animals; Benzhydryl Compounds; Biological Availability; Biotransformation; Chemistry, Pharmaceutical; Cresols; Drug Carriers; Hydrogels; Injections, Intravenous; Male; Mice; Models, Biological; Muscarinic Antagonists; Muscle Contraction; Permeability; Phenylpropanolamine; Pyrrolidinones; Rabbits; Rats; Skin; Skin Absorption; Skin Irritancy Tests; Technology, Pharmaceutical; Tolterodine Tartrate; Urinary Bladder; Urinary Bladder, Overactive; Urological Agents

2013
Tolterodine activates the prefrontal cortex during bladder filling in OAB patients: a real-time NIRS-urodynamics study.
    Neurourology and urodynamics, 2014, Volume: 33, Issue:7

    Topics: Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prefrontal Cortex; Spectroscopy, Near-Infrared; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urodynamics; Urological Agents

2014
Combination of foot stimulation and tolterodine treatment eliminates bladder overactivity in cats.
    Neurourology and urodynamics, 2014, Volume: 33, Issue:8

    Topics: Animals; Benzhydryl Compounds; Cats; Combined Modality Therapy; Cresols; Female; Foot; Male; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Transcutaneous Electric Nerve Stimulation; Urinary Bladder, Overactive

2014
Clinical and urodynamic effects of tolterodine in women with an overactive bladder.
    Taiwanese journal of obstetrics & gynecology, 2013, Volume: 52, Issue:3

    Topics: Adult; Aged; Benzhydryl Compounds; Cresols; Female; Humans; Menopause; Middle Aged; Nocturia; Parity; Phenylpropanolamine; Pregnancy; Retrospective Studies; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Urodynamics; Urological Agents

2013
Increased serum adipokines implicate chronic inflammation in the pathogenesis of overactive bladder syndrome refractory to antimuscarinic therapy.
    PloS one, 2013, Volume: 8, Issue:10

    Topics: Adipokines; Adult; Aged; Benzhydryl Compounds; C-Reactive Protein; Case-Control Studies; Cresols; Drug Resistance; Female; Humans; Inflammation; Male; Middle Aged; Muscarinic Antagonists; Nerve Growth Factor; Phenylpropanolamine; Prospective Studies; Tolterodine Tartrate; Urinary Bladder, Overactive

2013
Factors influencing patient satisfaction with antimuscarinic treatment of overactive bladder syndrome: results of a real-life clinical study.
    International journal of urology : official journal of the Japanese Urological Association, 2014, Volume: 21, Issue:4

    Topics: Aged; Aged, 80 and over; Benzhydryl Compounds; Benzilates; Cresols; Cross-Sectional Studies; Female; Humans; Imidazoles; Japan; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Patient Satisfaction; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive

2014
Therapeutic benefit in patients switching tolterodine to other novel antimuscarinic agents.
    Actas urologicas espanolas, 2014, Volume: 38, Issue:3

    Topics: Activities of Daily Living; Adult; Aged; Benzhydryl Compounds; Comorbidity; Cresols; Cross-Sectional Studies; Drug Substitution; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Muscarinic Antagonists; Observational Studies as Topic; Patient Preference; Patient Satisfaction; Personal Satisfaction; Phenylpropanolamine; Physicians; Propensity Score; Quinuclidines; Retrospective Studies; Sample Size; Solifenacin Succinate; Tetrahydroisoquinolines; Therapeutic Equivalency; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents; Young Adult

2014
Health economics perspective of fesoterodine, tolterodine or solifenacin as first-time therapy for overactive bladder syndrome in the primary care setting in Spain.
    BMC urology, 2013, Oct-21, Volume: 13

    Topics: Aged; Benzhydryl Compounds; Cholinergic Agents; Cost-Benefit Analysis; Cresols; Female; Health Care Costs; Humans; Male; Phenylpropanolamine; Prevalence; Primary Health Care; Quinuclidines; Retrospective Studies; Solifenacin Succinate; Spain; Syndrome; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents

2013
Design of transparent film-forming hydrogels of tolterodine and their effects on stratum corneum.
    International journal of pharmaceutics, 2014, Aug-25, Volume: 471, Issue:1-2

    Topics: Administration, Cutaneous; Animals; Benzhydryl Compounds; Cresols; Drug Carriers; Drug Compounding; Drug Design; Drug Liberation; Female; Hydrogels; Mice, Inbred Strains; Muscarinic Antagonists; Phase Transition; Phenylpropanolamine; Rats, Sprague-Dawley; Skin; Skin Absorption; Spectroscopy, Fourier Transform Infrared; Surface Properties; Tissue Distribution; Tolterodine Tartrate; Urinary Bladder, Overactive

2014
Are we shortchanging frail older people when it comes to the pharmacological treatment of urgency urinary incontinence?
    International journal of clinical practice, 2014, Volume: 68, Issue:9

    Topics: Aged; Aged, 80 and over; Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Frail Elderly; Humans; Muscarinic Antagonists; Phenylpropanolamine; Urinary Bladder, Overactive; Urinary Incontinence

2014
Influence of antimuscarinic therapy on cognitive functions and quality of life in geriatric patients treated for overactive bladder.
    Aging & mental health, 2015, Volume: 19, Issue:3

    Topics: Activities of Daily Living; Aged; Aged, 80 and over; Benzhydryl Compounds; Benzilates; Benzofurans; Cognition Disorders; Cresols; Depression; Female; Follow-Up Studies; Geriatric Assessment; Humans; Male; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Pyrrolidines; Quality of Life; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive

2015
Single uroflow study as a tool in predicting the possibility of abnormal voiding symptoms after the administration of antimuscarinic agents in treating overactive bladder syndrome.
    Clinical and experimental obstetrics & gynecology, 2015, Volume: 42, Issue:2

    Topics: Adult; Aged; Benzhydryl Compounds; Cresols; Female; Humans; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Retrospective Studies; Syndrome; Tolterodine Tartrate; Urinary Bladder, Overactive; Urination Disorders; Urodynamics; Young Adult

2015
Editorial comment on: Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate size.
    European urology, 2009, Volume: 55, Issue:2

    Topics: Adrenergic alpha-Antagonists; Aged; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Humans; Male; Middle Aged; Muscarinic Agonists; Organ Size; Phenylpropanolamine; Prostate; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Tract; Urination

2009
Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate size.
    European urology, 2009, Volume: 55, Issue:2

    Topics: Adrenergic alpha-Antagonists; Adult; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Diuresis; Drug Therapy, Combination; Humans; Male; Middle Aged; Multicenter Studies as Topic; Muscarinic Agonists; Organ Size; Phenylpropanolamine; Prostate; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Retention

2009
Editorial comment on: Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate size.
    European urology, 2009, Volume: 55, Issue:2

    Topics: Adrenergic alpha-Antagonists; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Male; Muscarinic Agonists; Organ Size; Phenylpropanolamine; Prostate; Safety; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Urinary Bladder Neck Obstruction; Urinary Bladder, Overactive; Urologic Diseases

2009
Editorial comment on: Is there a synergistic effect of topical oestrogens when administered with antimuscarinics in the treatment of symptomatic detrusor overactivity?
    European urology, 2009, Volume: 55, Issue:3

    Topics: Administration, Topical; Benzhydryl Compounds; Cresols; Drug Synergism; Drug Therapy, Combination; Estrogens; Female; Humans; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder, Overactive

2009
Editorial comment on: Is there a synergistic effect of topical oestrogens when administered with antimuscarinics in the treatment of symptomatic detrusor overactivity?
    European urology, 2009, Volume: 55, Issue:3

    Topics: Administration, Topical; Benzhydryl Compounds; Cresols; Drug Synergism; Drug Therapy, Combination; Estrogens; Female; Humans; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder, Overactive

2009
The effects of reformulation: improved therapeutic index.
    Current urology reports, 2008, Volume: 9, Issue:6

    Topics: Benzhydryl Compounds; Benzilates; Chemistry, Pharmaceutical; Cresols; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder, Overactive

2008
Comparison of receptor binding characteristics of commonly used muscarinic antagonists in human bladder detrusor and mucosa.
    The Journal of pharmacology and experimental therapeutics, 2009, Volume: 328, Issue:3

    Topics: Aged; Benzhydryl Compounds; Benzofurans; Cresols; Cystectomy; Female; Humans; Male; Middle Aged; Mucous Membrane; Muscarinic Antagonists; Phenylpropanolamine; Prostatectomy; Pyrrolidines; Quinuclidines; Quinuclidinyl Benzilate; Radioligand Assay; Receptors, Muscarinic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder; Urinary Bladder, Overactive

2009
Editorial comment on: Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with alpha-blockers.
    European urology, 2009, Volume: 56, Issue:3

    Topics: Adrenergic alpha-Antagonists; Benzhydryl Compounds; Cresols; Drug Therapy, Combination; Humans; Male; Muscarinic Antagonists; Phenylpropanolamine; Prostatism; Tolterodine Tartrate; Urinary Bladder, Overactive

2009
Editorial comment on: Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with alpha-blockers.
    European urology, 2009, Volume: 56, Issue:3

    Topics: Adrenergic alpha-Antagonists; Benzhydryl Compounds; Cresols; Drug Therapy, Combination; Humans; Male; Muscarinic Antagonists; Phenylpropanolamine; Prostatism; Tolterodine Tartrate; Urinary Bladder, Overactive

2009
A multicomponent behavioural and drug intervention for nocturia in elderly men: rationale and pilot results.
    BJU international, 2009, Volume: 104, Issue:1

    Topics: Acetamides; Adrenergic alpha-Antagonists; Aged; Behavior Therapy; Benzhydryl Compounds; Combined Modality Therapy; Cresols; Epidemiologic Methods; Humans; Hypnotics and Sedatives; Male; Middle Aged; Muscarinic Antagonists; Nocturia; Phenylpropanolamine; Prazosin; Prostatic Hyperplasia; Pyrimidines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive

2009
Decrease of urinary nerve growth factor levels after antimuscarinic therapy in patients with overactive bladder.
    BJU international, 2009, Volume: 103, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Biomarkers; Case-Control Studies; Cresols; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Nerve Growth Factor; Phenylpropanolamine; Prognosis; Severity of Illness Index; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urodynamics

2009
Correlations among improvements in urgency urinary incontinence, health-related quality of life, and perception of bladder-related problems in incontinent subjects with overactive bladder treated with tolterodine or placebo.
    Health and quality of life outcomes, 2009, Feb-18, Volume: 7

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Benzhydryl Compounds; Cresols; Female; Humans; Male; Medical Records; Middle Aged; Muscarinic Antagonists; Patient Satisfaction; Phenylpropanolamine; Placebos; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Young Adult

2009
Combined effects of behavioral intervention and tolterodine in patients dissatisfied with overactive bladder medication.
    The Journal of urology, 2009, Volume: 181, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Behavior Therapy; Benzhydryl Compounds; Combined Modality Therapy; Cresols; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Patient Satisfaction; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder, Overactive; Young Adult

2009
Cost-effectiveness analysis of solifenacin flexible dosing in patients with overactive bladder symptoms in four Nordic countries.
    Acta obstetricia et gynecologica Scandinavica, 2009, Volume: 88, Issue:6

    Topics: Benzhydryl Compounds; Cost-Benefit Analysis; Cresols; Decision Support Techniques; Female; Finland; Humans; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Randomized Controlled Trials as Topic; Scandinavian and Nordic Countries; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive

2009
Solifenacin in the treatment of overactive bladder syndrome in Italian patients: pharmacoeconomic evaluation.
    Journal of medical economics, 2009, Volume: 12, Issue:1

    Topics: Benzhydryl Compounds; Computer Simulation; Cost-Benefit Analysis; Cresols; Humans; Italy; Markov Chains; Muscarinic Antagonists; Pharmacogenetics; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Incontinence

2009
Anticholinergic drug use for overactive bladder in Sweden: a nationwide pharmacoepidemiological study.
    International urogynecology journal and pelvic floor dysfunction, 2009, Volume: 20, Issue:11

    Topics: Benzhydryl Compounds; Benzofurans; Cholinergic Antagonists; Cresols; Female; Health Care Costs; Humans; Muscarinic Antagonists; Pharmacoepidemiology; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Registries; Retrospective Studies; Solifenacin Succinate; Sweden; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive

2009
Editorial comment.
    The Journal of urology, 2009, Volume: 182, Issue:4 Suppl

    Topics: Benzhydryl Compounds; Child; Cresols; Drug Therapy, Combination; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder, Overactive

2009
Editorial comment.
    The Journal of urology, 2009, Volume: 182, Issue:4 Suppl

    Topics: Benzhydryl Compounds; Child; Cresols; Drug Therapy, Combination; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder, Overactive

2009
Editorial comment.
    The Journal of urology, 2009, Volume: 182, Issue:4 Suppl

    Topics: Benzhydryl Compounds; Child; Cresols; Drug Therapy, Combination; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder, Overactive

2009
Symptomatic and quality of life response to tolterodine in subgroups of men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia.
    World journal of urology, 2010, Volume: 28, Issue:3

    Topics: Adrenergic alpha-Antagonists; Age Factors; Aged; Benzhydryl Compounds; Cresols; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Patient Satisfaction; Phenylpropanolamine; Probability; Prospective Studies; Prostatic Hyperplasia; Prostatism; Quality of Life; Regression Analysis; Severity of Illness Index; Statistics, Nonparametric; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urodynamics

2010
[Clinical efficacy of tolterodine for patients with overactive bladder after insufficient efficacy by monotherapy with alpha1-adrenoceptor antagonist].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2009, Volume: 100, Issue:7

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prostatic Hyperplasia; Quality of Life; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive

2009
Pharmacological and genetic analysis of mechanisms underlying detrusor overactivity in rats.
    Neurourology and urodynamics, 2010, Volume: 29, Issue:1

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Afferent Pathways; Animals; Benzhydryl Compounds; Brain; Cerebral Infarction; Cresols; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Early Growth Response Protein 1; Excitatory Amino Acid Antagonists; Muscarinic Antagonists; Muscle Contraction; Nerve Fibers, Unmyelinated; Neuronal Plasticity; Phenylpropanolamine; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP1 Subtype; RNA, Messenger; Sulfonamides; Tamsulosin; Time Factors; Tolterodine Tartrate; Transcription, Genetic; Urinary Bladder; Urinary Bladder, Overactive

2010
The cost-effectiveness of solifenacin vs fesoterodine, oxybutynin immediate-release, propiverine, tolterodine extended-release and tolterodine immediate-release in the treatment of patients with overactive bladder in the UK National Health Service.
    BJU international, 2010, Volume: 106, Issue:4

    Topics: Benzhydryl Compounds; Benzilates; Cost-Benefit Analysis; Cresols; Decision Trees; Delayed-Action Preparations; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive

2010
Pediatrics: combining antimuscarinics shows promise for overactive bladder.
    Nature reviews. Urology, 2010, Volume: 7, Issue:2

    Topics: Benzhydryl Compounds; Child; Cresols; Drug Therapy, Combination; Humans; Mandelic Acids; Muscarinic Antagonists; Pediatrics; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive

2010
Efficacy and safety of tolterodine extended release and dutasteride in male overactive bladder patients with prostates >30 grams.
    Urology, 2010, Volume: 75, Issue:5

    Topics: Azasteroids; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Dutasteride; Humans; Male; Middle Aged; Muscarinic Antagonists; Organ Size; Phenylpropanolamine; Prostate; Prostatism; Tolterodine Tartrate; Urinary Bladder, Overactive

2010
A prospective observational study of the effects of treatment with extended-release tolterodine on health-related quality of life of patients suffering overactive bladder syndrome in Sweden.
    Scandinavian journal of urology and nephrology, 2010, Volume: 44, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Quality of Life; Sweden; Syndrome; Tolterodine Tartrate; Urinary Bladder, Overactive

2010
Fesoterodine fumarate.
    Drugs of today (Barcelona, Spain : 1998), 2010, Volume: 46, Issue:2

    Topics: Animals; Benzhydryl Compounds; Clinical Trials as Topic; Cresols; Humans; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Tolterodine Tartrate; Urinary Bladder, Overactive

2010
The cost-effectiveness of solifenacin vs fesoterodine, oxybutynin immediate-release, propiverine, tolterodine extended-release and tolterodine immediate-release in the treatment of patients with overactive bladder in the UK National Health Service.
    BJU international, 2010, Volume: 106, Issue:4

    Topics: Benzhydryl Compounds; Cost-Benefit Analysis; Cresols; Humans; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder, Overactive

2010
Efficacy of extended-release tolterodine for the treatment of neurogenic detrusor overactivity and/or low-compliance bladder.
    International journal of urology : official journal of the Japanese Urological Association, 2010, Volume: 17, Issue:11

    Topics: Adult; Aged; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Muscarinic Antagonists; Patient Satisfaction; Phenylpropanolamine; Prospective Studies; Quality of Life; Statistics, Nonparametric; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Neurogenic; Urinary Bladder, Overactive; Urodynamics

2010
Validation of the urinary sensation scale (USS).
    Neurourology and urodynamics, 2011, Volume: 30, Issue:3

    Topics: Aged; Benzhydryl Compounds; Cresols; Female; Humans; Linear Models; Male; Multicenter Studies as Topic; Muscarinic Antagonists; Perception; Phenylpropanolamine; Predictive Value of Tests; Randomized Controlled Trials as Topic; Reproducibility of Results; Sensation; Surveys and Questionnaires; Tolterodine Tartrate; Urinary Bladder; Urinary Bladder, Overactive; Urodynamics

2011
Efficacy and tolerability of solifenacin in patients aged ≥ 65 years with overactive bladder: post-hoc analysis of 2 open-label studies.
    Postgraduate medicine, 2011, Volume: 123, Issue:1

    Topics: Aged; Aged, 80 and over; Benzhydryl Compounds; Clinical Trials as Topic; Cresols; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive

2011
A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder.
    British journal of clinical pharmacology, 2011, Volume: 72, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; Benzhydryl Compounds; Benzofurans; Blood-Brain Barrier; Brain; Cell Line; Chromatography, High Pressure Liquid; Cresols; Humans; Male; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Solifenacin Succinate; Tandem Mass Spectrometry; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive

2011
FDA approval signals more 'homework' on the horizon in trials.
    Nature medicine, 2011, Jul-07, Volume: 17, Issue:7

    Topics: Benzhydryl Compounds; Clinical Trials as Topic; Cresols; Drug Approval; Humans; Muscarinic Antagonists; Phenylpropanolamine; Self Administration; Tolterodine Tartrate; United States; United States Food and Drug Administration; Urinary Bladder, Overactive

2011
Reliability and responsiveness of the Urgency Severity and Life Impact Questionnaire (USIQ).
    International urogynecology journal, 2012, Volume: 23, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Female; Humans; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Reproducibility of Results; Severity of Illness Index; Surveys and Questionnaires; Tolterodine Tartrate; Urinary Bladder, Overactive

2012
Re: Symptomatic and quality of life response to tolterodine in subgroups of men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia.
    The Journal of urology, 2011, Volume: 185, Issue:4

    Topics: Benzhydryl Compounds; Cresols; Humans; Male; Muscarinic Antagonists; Phenylpropanolamine; Prostatic Hyperplasia; Prostatism; Quality of Life; Urinary Bladder, Overactive

2011
Cost-effectiveness of percutaneous tibial nerve stimulation versus extended release tolterodine for overactive bladder.
    The Journal of urology, 2012, Volume: 187, Issue:1

    Topics: Benzhydryl Compounds; Cost-Benefit Analysis; Cresols; Decision Trees; Delayed-Action Preparations; Female; Humans; Muscarinic Antagonists; Phenylpropanolamine; Tibial Nerve; Tolterodine Tartrate; Transcutaneous Electric Nerve Stimulation; Urinary Bladder, Overactive

2012
Silicone adhesive, a better matrix for tolterodine patches-a research based on in vitro/in vivo studies.
    Drug development and industrial pharmacy, 2012, Volume: 38, Issue:8

    Topics: Adhesives; Administration, Cutaneous; Animals; Benzhydryl Compounds; Biological Availability; Chemistry, Pharmaceutical; Cresols; Drug Delivery Systems; Male; Myristates; Phenylpropanolamine; Rabbits; Silicones; Skin; Skin Absorption; Tolterodine Tartrate; Transdermal Patch; Urinary Bladder, Overactive

2012
Modulation of non-voiding activity by the muscarinergic antagonist tolterodine and the β(3)-adrenoceptor agonist mirabegron in conscious rats with partial outflow obstruction.
    BJU international, 2012, Volume: 110, Issue:2 Pt 2

    Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Animals; Benzhydryl Compounds; Cresols; Dose-Response Relationship, Drug; Female; Infusions, Intravenous; Muscarinic Antagonists; Phenylpropanolamine; Rats; Rats, Sprague-Dawley; Thiazoles; Tolterodine Tartrate; Urinary Bladder Neck Obstruction; Urinary Bladder, Overactive; Urination

2012
Dose and aging effect on patients reported treatment benefit switching from the first overactive bladder therapy with tolterodine ER to fesoterodine: post-hoc analysis from an observational and retrospective study.
    BMC urology, 2012, Jul-26, Volume: 12

    Topics: Aged; Aging; Benzhydryl Compounds; Cohort Studies; Cresols; Cross-Sectional Studies; Delayed-Action Preparations; Drug Substitution; Female; Humans; Male; Middle Aged; Phenylpropanolamine; Retrospective Studies; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive

2012
Combination of baclofen and antimuscarinics to reduce voiding difficulty in treating women with overactive bladders.
    Clinical and experimental obstetrics & gynecology, 2012, Volume: 39, Issue:2

    Topics: Adult; Aged; Baclofen; Benzhydryl Compounds; Community-Based Participatory Research; Cresols; Drug Therapy, Combination; Female; Humans; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder, Overactive; Urination; Urodynamics; Young Adult

2012
Efficacy and tolerability of fesoterodine versus tolterodine in older and younger subjects with overactive bladder: a post hoc, pooled analysis from two placebo-controlled trials.
    Neurourology and urodynamics, 2012, Volume: 31, Issue:8

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Randomized Controlled Trials as Topic; Surveys and Questionnaires; Time Factors; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Urination; Young Adult

2012
Re: Cost-effectiveness of percutaneous tibial nerve stimulation versus extended release tolterodine for overactive bladder: H. W. Chen, R. S. Bercik, E. F. Werner And S. F. Thung; J Urol 2012; 187: 178-184.
    The Journal of urology, 2012, Volume: 188, Issue:6

    Topics: Benzhydryl Compounds; Cresols; Female; Humans; Muscarinic Antagonists; Phenylpropanolamine; Transcutaneous Electric Nerve Stimulation; Urinary Bladder, Overactive

2012
Mirabegron as a new class of oral drug for overactive bladder syndrome: many positive perspectives, some concerns.
    European urology, 2013, Volume: 63, Issue:2

    Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Benzhydryl Compounds; Cresols; Female; Humans; Male; Muscarinic Antagonists; Phenylpropanolamine; Thiazoles; Tolterodine Tartrate; Urinary Bladder, Overactive

2013
[Comment on the STAR study: Comparison of the efficacy and tolerance of solifenacin and tolterodine retard in the treatment of overactive bladder].
    Der Urologe. Ausg. A, 2006, Volume: 45, Issue:7

    Topics: Analysis of Variance; Benzhydryl Compounds; Controlled Clinical Trials as Topic; Cresols; Double-Blind Method; Drug Tolerance; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence

2006
Re: safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction.
    The Journal of urology, 2006, Volume: 176, Issue:5

    Topics: Benzhydryl Compounds; Cresols; Humans; Male; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder Neck Obstruction; Urinary Bladder, Overactive

2006
Retrospective evaluation of outcomes in patients with overactive bladder receiving tolterodine versus oxybutynin.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2006, Dec-01, Volume: 63, Issue:23

    Topics: Benzhydryl Compounds; Comorbidity; Cresols; Delayed-Action Preparations; Depression; Female; Fractures, Bone; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Retrospective Studies; Risk; Tolterodine Tartrate; United States; Urinary Bladder, Overactive; Urinary Tract Infections

2006
[More quality of life again with tolterodine].
    Praxis, 2006, Oct-18, Volume: 95, Issue:42

    Topics: Benzhydryl Compounds; Cresols; Humans; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Tolterodine Tartrate; Urinary Bladder, Overactive

2006
Pharmacological characterization of a new antimuscarinic agent, solifenacin succinate, in comparison with other antimuscarinic agents.
    Biological & pharmaceutical bulletin, 2007, Volume: 30, Issue:1

    Topics: Animals; Atropine; Benzhydryl Compounds; Benzilates; Benzofurans; Binding, Competitive; Carbachol; CHO Cells; Cholinergic Agonists; Cresols; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Mandelic Acids; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; N-Methylscopolamine; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Muscarinic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Transfection; Urinary Bladder; Urinary Bladder, Overactive; Urination

2007
Comparative evaluation of central muscarinic receptor binding activity by oxybutynin, tolterodine and darifenacin used to treat overactive bladder.
    The Journal of urology, 2007, Volume: 177, Issue:2

    Topics: Animals; Benzhydryl Compounds; Benzofurans; Cerebral Cortex; Cresols; In Vitro Techniques; Male; Mandelic Acids; Mice; Muscarinic Antagonists; Phenylpropanolamine; Pyrrolidines; Receptors, Muscarinic; Tolterodine Tartrate; Urinary Bladder; Urinary Bladder, Overactive

2007
[Urinary symptoms and urodynamic findings in Parkinson's disease].
    Neurologia (Barcelona, Spain), 2007, Volume: 22, Issue:2

    Topics: Aged; Benzhydryl Compounds; Cresols; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Parkinson Disease; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Urodynamics

2007
Treatment of men with lower urinary tract symptoms and overactive bladder.
    JAMA, 2007, Mar-21, Volume: 297, Issue:11

    Topics: Adrenergic alpha-Antagonists; Aged; Benzhydryl Compounds; Cost-Benefit Analysis; Cresols; Drug Therapy, Combination; Humans; Male; Muscarinic Antagonists; Patient Satisfaction; Phenylpropanolamine; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge

2007
Treatment of men with lower urinary tract symptoms and overactive bladder.
    JAMA, 2007, Mar-21, Volume: 297, Issue:11

    Topics: Adrenergic Agonists; Adrenergic alpha-Antagonists; Aged; Benzhydryl Compounds; Cresols; Drug Interactions; Drug Therapy, Combination; Histamine H1 Antagonists; Humans; Male; Muscarinic Antagonists; Phenylpropanolamine; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Incontinence, Urge

2007
[Comment on the STAR study: Comparison of the efficacy and tolerance of solifenacin and tolterodine retard in the treatment of overactive bladder].
    Der Urologe. Ausg. A, 2007, Volume: 46, Issue:4

    Topics: Analysis of Variance; Benzhydryl Compounds; Cresols; Double-Blind Method; Drug Tolerance; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive

2007
Long-term efficacy of tolterodine and patient compliance in pediatric patients with neurogenic detrusor overactivity.
    Urologia internationalis, 2007, Volume: 79, Issue:1

    Topics: Benzhydryl Compounds; Child; Cresols; Female; Follow-Up Studies; Humans; Male; Muscarinic Antagonists; Patient Compliance; Phenylpropanolamine; Time Factors; Tolterodine Tartrate; Urinary Bladder, Neurogenic; Urinary Bladder, Overactive

2007
Cognitive dysfunction with tolterodine use.
    American journal of obstetrics and gynecology, 2007, Volume: 197, Issue:2

    Topics: Aged; Benzhydryl Compounds; Cognition Disorders; Cresols; Female; Humans; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder, Overactive

2007
Efficacy of tolterodine in women with detrusor overactivity and anterior vaginal wall prolapse: is it the same?
    BJOG : an international journal of obstetrics and gynaecology, 2007, Volume: 114, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Female; Humans; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Uterine Prolapse

2007
Effects of antimuscarinics on voiding function after cerebral infarction in a rat model of overactive bladder.
    European journal of pharmacology, 2007, Dec-22, Volume: 577, Issue:1-3

    Topics: Animals; Atropine; Benzhydryl Compounds; Cresols; Dose-Response Relationship, Drug; Female; Infarction, Middle Cerebral Artery; Injections, Intraventricular; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; Phenylpropanolamine; Rats; Rats, Sprague-Dawley; Tolterodine Tartrate; Urinary Bladder; Urinary Bladder, Overactive; Urinary Catheterization; Urination

2007
Editorial comment on: Urinary incontinence at orgasm: relation to detrusor overactivity and treatment efficacy.
    European urology, 2008, Volume: 54, Issue:4

    Topics: Benzhydryl Compounds; Cresols; Female; Humans; Muscarinic Antagonists; Orgasm; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence

2008
Editorial comment on: Urinary incontinence at orgasm: relation to detrusor overactivity and treatment efficacy.
    European urology, 2008, Volume: 54, Issue:4

    Topics: Benzhydryl Compounds; Cresols; Female; Humans; Muscarinic Antagonists; Orgasm; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence

2008
Urinary incontinence at orgasm: relation to detrusor overactivity and treatment efficacy.
    European urology, 2008, Volume: 54, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Female; Humans; Middle Aged; Muscarinic Antagonists; Orgasm; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Young Adult

2008
Thorough QT study with recommended and supratherapeutic doses of tolterodine.
    Clinical pharmacology and therapeutics, 2008, Volume: 83, Issue:2

    Topics: Benzhydryl Compounds; Cresols; Dose-Response Relationship, Drug; Drug Labeling; Humans; Long QT Syndrome; Muscarinic Antagonists; Patient Selection; Phenylpropanolamine; Research Design; Risk Assessment; Risk Factors; Tolterodine Tartrate; Urinary Bladder, Overactive

2008
Efficacy of tolterodine in relation to different urodynamic findings of detrusor overactivity.
    International urogynecology journal and pelvic floor dysfunction, 2008, Volume: 19, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Body Mass Index; Cresols; Female; Follow-Up Studies; Humans; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urodynamics

2008
The effects of a type 4 phosphodiesterase inhibitor and the muscarinic cholinergic antagonist tolterodine tartrate on detrusor overactivity in female rats with bladder outlet obstruction.
    BJU international, 2008, Volume: 101, Issue:5

    Topics: Animals; Benzhydryl Compounds; Cresols; Female; Muscarinic Antagonists; Muscle, Smooth; Phenylpropanolamine; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Tolterodine Tartrate; Urinary Bladder; Urinary Bladder Neck Obstruction; Urinary Bladder, Overactive; Urodynamics

2008
In vivo characterization of muscarinic receptors in peripheral tissues: evaluation of bladder selectivity of anticholinergic agents to treat overactive bladder.
    Naunyn-Schmiedeberg's archives of pharmacology, 2008, Volume: 377, Issue:4-6

    Topics: Administration, Oral; Animals; Area Under Curve; Benzhydryl Compounds; Benzilates; Cholinergic Antagonists; Cresols; Male; Mandelic Acids; Mice; Muscarinic Antagonists; Phenylpropanolamine; Protein Binding; Quinuclidinyl Benzilate; Receptors, Muscarinic; Time Factors; Tolterodine Tartrate; Urinary Bladder, Overactive

2008
Persistence, adherence, and switch rates among extended-release and immediate-release overactive bladder medications in a regional managed care plan.
    Journal of managed care pharmacy : JMCP, 2008, Volume: 14, Issue:3

    Topics: Adult; Aged; Benzhydryl Compounds; Cohort Studies; Cresols; Databases, Factual; Delayed-Action Preparations; Female; Follow-Up Studies; Humans; Male; Managed Care Programs; Mandelic Acids; Middle Aged; Multivariate Analysis; Muscarinic Antagonists; Patient Compliance; Phenylpropanolamine; Retrospective Studies; Tolterodine Tartrate; Treatment Refusal; United States; Urinary Bladder, Overactive

2008
Human urine with solifenacin intake but not tolterodine or darifenacin intake blocks detrusor overactivity.
    International urogynecology journal and pelvic floor dysfunction, 2008, Volume: 19, Issue:10

    Topics: Administration, Oral; Animals; Benzhydryl Compounds; Benzofurans; Cresols; Disease Models, Animal; Female; Humans; Muscarinic Antagonists; Muscle, Smooth; Phenylpropanolamine; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M3; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urine

2008